Impact of disease-modifying therapies on MRI and neurocognitive outcomes in relapsing–remitting multiple sclerosis: a protocol for a systematic review and network meta-analysis

INTRODUCTION: Disease-modifying therapies (DMTs) are the mainstay of treatment for relapsing–remitting multiple sclerosis (RRMS). There is established evidence that DMTs are effective at reducing relapse rate and disease progression in RRMS, but there has been less consideration to the synthesis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lees, Samuel, Dicker, Mathew, Ku, Jie En, Chaganti, Varun, Mew-Sum, Matthew, Wang, Nick, Smith, Angela, Oldmeadow, Christopher, Goon, Wooi Lynn, Bevan, Marc, Lang, Danielle, Hinwood, Madeleine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565566/
https://www.ncbi.nlm.nih.gov/pubmed/34728450
http://dx.doi.org/10.1136/bmjopen-2021-051509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565566/
https://www.ncbi.nlm.nih.gov/pubmed/34728450
http://dx.doi.org/10.1136/bmjopen-2021-051509

Ejemplares similares